Biogen, Inc. (BIIB)
191.95
-17.08
(-8.17%)
USD |
NASDAQ |
Jul 14, 16:00
191.89
-0.06
(-0.03%)
After-Hours: 06:40
Biogen Market Cap : 28.33B for July 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| July 14, 2026 | 28.33B |
| July 13, 2026 | 30.85B |
| July 10, 2026 | 29.39B |
| July 09, 2026 | 29.36B |
| July 08, 2026 | 29.57B |
| July 07, 2026 | 30.36B |
| July 06, 2026 | 30.77B |
| July 02, 2026 | 31.90B |
| July 01, 2026 | 30.96B |
| June 30, 2026 | 31.89B |
| June 29, 2026 | 31.97B |
| June 26, 2026 | 31.89B |
| June 25, 2026 | 29.81B |
| June 24, 2026 | 29.46B |
| June 23, 2026 | 29.11B |
| June 22, 2026 | 29.48B |
| June 18, 2026 | 29.02B |
| June 17, 2026 | 29.32B |
| June 16, 2026 | 28.87B |
| June 15, 2026 | 29.32B |
| June 12, 2026 | 29.53B |
| June 11, 2026 | 29.51B |
| June 10, 2026 | 28.67B |
| June 09, 2026 | 29.39B |
| June 08, 2026 | 28.43B |
| Date | Value |
|---|---|
| June 05, 2026 | 28.83B |
| June 04, 2026 | 29.00B |
| June 03, 2026 | 28.92B |
| June 02, 2026 | 27.87B |
| June 01, 2026 | 28.37B |
| May 29, 2026 | 28.93B |
| May 28, 2026 | 28.99B |
| May 27, 2026 | 29.08B |
| May 26, 2026 | 28.51B |
| May 22, 2026 | 28.61B |
| May 21, 2026 | 27.97B |
| May 20, 2026 | 27.73B |
| May 19, 2026 | 28.13B |
| May 18, 2026 | 28.33B |
| May 15, 2026 | 28.49B |
| May 14, 2026 | 28.25B |
| May 13, 2026 | 30.20B |
| May 12, 2026 | 29.43B |
| May 11, 2026 | 29.22B |
| May 08, 2026 | 28.56B |
| May 07, 2026 | 28.25B |
| May 06, 2026 | 28.15B |
| May 05, 2026 | 27.92B |
| May 04, 2026 | 27.64B |
| May 01, 2026 | 27.62B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 432.46B |
| Ionis Pharmaceuticals, Inc. | 9.113B |
| Gilead Sciences, Inc. | 161.51B |
| Regeneron Pharmaceuticals, Inc. | 68.89B |
| Amgen, Inc. | 191.73B |
Market Cap Related Metrics
| PE Ratio | 20.60 |
| PS Ratio | 2.944 |
| Price to Book Value | 1.519 |
| Price to Free Cash Flow | 12.20 |
| Price | 191.95 |
| Earnings Yield | 4.85% |
| Operating PE Ratio | 12.33 |
| Normalized PE Ratio | 16.91 |